A share price of Compass Therapeutics Inc [CMPX] is currently trading at $1.50, up 0.67%. An important factor to consider is whether the stock is rising or falling in short-term value. The CMPX shares have gain 11.11% over the last week, with a monthly amount drifted -12.79%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Compass Therapeutics Inc [NASDAQ: CMPX] stock has seen the most recent analyst activity on November 15, 2024, when Leerink Partners downgraded its rating to a Market Perform and also revised its price target to $4 from $5. Previously, Ladenburg Thalmann upgraded its rating to Buy on September 16, 2024, and kept the price target unchanged to $5. On January 31, 2023, Jefferies initiated with a Buy rating and assigned a price target of $8 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $9 on January 27, 2023. Ladenburg Thalmann started tracking with a Buy rating for this stock on March 15, 2022, and assigned it a price target of $7. In a note dated January 19, 2022, B. Riley Securities initiated an Buy rating and provided a target price of $10 on this stock.
Compass Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $0.76 and $2.34. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Compass Therapeutics Inc [NASDAQ: CMPX] shares were valued at $1.50 at the most recent close of the market. An investor can expect a potential return of 233.33% based on the average CMPX price forecast.
Analyzing the CMPX fundamentals
Gross Profit Margin for this corporation currently stands at 0.34% with Operating Profit Margin at -18.79%, Pretax Profit Margin comes in at -15.98%, and Net Profit Margin reading is -15.98%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.29 and Total Capital is -0.34. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4600 points at the first support level, and at 1.4200 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5800, and for the 2nd resistance point, it is at 1.6600.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Compass Therapeutics Inc [NASDAQ:CMPX] is 31.84. On the other hand, the Quick Ratio is 31.84, and the Cash Ratio is 6.08. Considering the valuation of this stock, the price to sales ratio is 262.16, the price to book ratio is 1.49.
